CTRI/2015/12/006458Not ApplicablePhase 1
COMPARATIVE EFFICACY OF HYPERTONIC(3%) SALINE VERSUS EPINEPHRINE NEBULISATION IN CHILDREN WITH ACUTE BRONCHIOLITIS- A RANDOMISED CONTROLLED TRIA
Trial Snapshot
- Phase
- Phase 1
- Status
- Not Applicable
- Sponsor
- BPKIHS
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •All children between 1 month and 5 years of age with the diagnosis of acute bronchiolitis. Bronchiolitis taken as the first episode of wheezing associated with clinical evidence of viral infection (cough, coryza or fever).
Exclusion Criteria
- •children over 5 yrs of age
- •not giving consent
- •Multiple episodes of wheezing
- •Children already on bronchodilators or any other medication
- •Children with history of allergic rhinitis, atopic dermatitis.
- •Children with cardiac disease
- •Children with chronic pulmonary disease
- •Children with obtunded consciousness
- •Children with progressive respiratory failure.
Investigators
Similar Trials
Recruiting
Phase 3
Comparison of the efficacy of hypertonic saline 5% with mannitol 20% on cerebral edema in ischemic and hemorrhagic stroke patientsIRCT20120215009014N480Hamedan University of Medical Sciences100
Completed
Not Applicable
A comparison of nebulized 3% hypertonic saline and epinephrine versus nebulized normal saline and epinephrine in the treatment of acute bronchiolitisRespiratoryBronchiolitisISRCTN66632312niversity of Alberta, Department of Pediatrics (Canada)46
Recruiting
Phase 3
The effect of hyper-tonic saline serum on the outcome of patients with severe strokeSever Ischemic stroke.IRCT20190311043008N1Ghoum University of Medical Sciences100
Recruiting
Phase 2
Effect of hypertonic saline3% in tramadol toxicityAcute tramadol toxicity and side effects.IRCT20220213054017N1Artesh University of Medical Sciences200
Completed
Phase 4
comparison of 2 drugs to manage brain swelling in patients with head injuryCTRI/2016/04/006829IMHANS38